FDA Inspection
UCB Pharma S.A.UCB Pharma S.A. – FDA Inspection, Jan 27, 2017
Record Details
This FDA Inspection record concerns UCB Pharma S.A., with an inspection on January 27, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b869769c-b1b8-4e08-b406-591c9e291b9f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1013309
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of UCB Pharma S.A.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Office of Inspections and Investigations | Compliance: Devices |
| February 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2023 | Not classified | Office of Inspections and Investigations | |
| November 25, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for UCB Pharma S.A.
- FDA Inspection 1323186 - 2026-06-04
- FDA Inspection 1247808 - 2024-02-01
- FDA Inspection 1208307 - 2023-04-21
- FDA Inspection 1170317 - 2021-11-25
- FDA Inspection 946302 - 2015-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.